Monday, July 15, 2019 1:23:02 PM
1) Have an independent board of directors. (Oops! Not there yet.)
from the 8K:
One such standard requires that we have a
majority of independent directors, which means that we need to increase the size of our board and appoint independent directors. The Company’s bylaws allow the
sole director to fix the number of directorsThe bylaws also state that newly created directorships resulting from any increase in the authorized number of directors
may be filled by the sole director. As a result of these bylaws provisions, Mr. Thompson, as sole director shall expand the number of directorships and appoint such
persons as he deems suitable for our board and that will help us to satisfy the listing standard requirements
KIM will be the first of many
2) Have 80 million in assets. (Oops! Not there yet.)
this could be prodigy if it starts production, as a wholly owned sub it will count as an asset
3) Have a stable price of at least $4 per share. A reverse split may move us up to that level, but I don't think we could hold it for long in the absence of product, sales, contracts, etc.
thus the reason for the reverse split
these are my opinions towards your three steps
from the 8K:
One such standard requires that we have a
majority of independent directors, which means that we need to increase the size of our board and appoint independent directors. The Company’s bylaws allow the
sole director to fix the number of directorsThe bylaws also state that newly created directorships resulting from any increase in the authorized number of directors
may be filled by the sole director. As a result of these bylaws provisions, Mr. Thompson, as sole director shall expand the number of directorships and appoint such
persons as he deems suitable for our board and that will help us to satisfy the listing standard requirements
KIM will be the first of many
2) Have 80 million in assets. (Oops! Not there yet.)
this could be prodigy if it starts production, as a wholly owned sub it will count as an asset
3) Have a stable price of at least $4 per share. A reverse split may move us up to that level, but I don't think we could hold it for long in the absence of product, sales, contracts, etc.
thus the reason for the reverse split
these are my opinions towards your three steps
Recent KBLB News
- Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations • GlobeNewswire Inc. • 05/26/2026 11:35:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:20 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:19 PM
- Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform • GlobeNewswire Inc. • 05/20/2026 11:35:00 AM
- Immortalized Silk Gland Cell Line Breakthrough Expands Kraig Biocraft’s Biotech Ambitions (KBLB) • IH Market News • 05/18/2026 03:12:33 PM
- Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications • GlobeNewswire Inc. • 05/18/2026 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:31:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/14/2026 12:14:08 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/14/2026 04:15:05 AM
- The Plastic Crisis Is Exploding and Kraig Biocraft Laboratories Has a Unique Answer • GlobeNewswire Inc. • 05/13/2026 01:05:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/11/2026 08:30:47 PM
- Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up • GlobeNewswire Inc. • 05/11/2026 11:05:00 AM
- Kraig Biocraft Laboratories Positions Itself as a Front-Runner in Spider Silk Race • GlobeNewswire Inc. • 05/07/2026 01:05:00 PM
- Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output • GlobeNewswire Inc. • 05/04/2026 11:05:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/30/2026 09:07:15 PM
- Kraig Biocraft (KBLB) Spider Silk Production Milestone Signals Progress Toward Commercialization • IH Market News • 04/30/2026 02:54:26 PM
- Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations • GlobeNewswire Inc. • 04/30/2026 01:20:00 PM
- Kraig Biocraft (USOTC:KBLB) Hits 50% Production Milestone — Spider Silk Push Moves Closer to Commercial Scale • IH Market News • 04/28/2026 01:51:39 PM
- Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk • GlobeNewswire Inc. • 04/28/2026 11:05:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/21/2026 06:41:52 PM
- Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons • GlobeNewswire Inc. • 04/20/2026 11:05:00 AM
- The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future • GlobeNewswire Inc. • 04/15/2026 01:15:00 PM
